EUVIMEDEUVIMED entdecken
Open Access

Cryopreserved Alginate-Encapsulated Islets Can Restore Euglycemia in a Diabetic Animal Model Better than Cryopreserved Non-encapsulated Islets

Greg G Kojayan, Antonio Flores, Shiri Li, Michael Alexander, Jonathan Rt Lakey iD

Cell Medicine · 2019

DOI: 10.1177/2155179019876641 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Medicine, 2019. Verfasst von Greg G Kojayan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California Irvine, Orange, CA, USA. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Islet transplantation has been shown to restore normoglycemia clinically. One of the current limitations to the widespread clinical use of islet transplantation is culturing and preserving more than 1 million islet equivalents in preparation for transplant. One possible solution is to bank frozen islets and use them when needed. Although promising, the standard islet freezing protocol introduces stress and cell death, resulting in high variability of islet quality post thawing. This study aimed to develop an improved cryopreservation protocol using alginate-encapsulated islets to improve islet survival and function for future transplants. Our data showed that encapsulation improved islet survival and function after thawing the frozen islets. Frozen encapsulated islets have an islet yield recovery of 84% when compared to non-encapsulated islets at 72% after thawing. Post-thaw viability was 78% for non-encapsulated islets compared to 88% for encapsulated islets. The stimulation index values after a static glucose test following thawing were 1.9 ± 0.5, 2.9 ± 0.1, and 3.3 ± 0.3 for the non-encapsulated, 1.75% alginate, and 2.5% alginate groups, respectively. In a transplant study, the mice that received 1.75% alginate-encapsulated cryopreserved islets achieved normoglycemia on average 5 days after transplant. In comparison, control mice that received fresh islets took 4 days, while those receiving unencapsulated cryopreserved islets took 18 days. In conclusion, encapsulating islets in 1.75% alginate prior to freezing was shown to improve islet survival, function post thawing, and graft response significantly when compared to islets frozen without encapsulation.

Schlagwörter

Stichwörter der Autor:innen

alginatecryopreservationdiabetesencapsulationislet

Autor:innen und Institutionen

  • Department of Surgery, University of California Irvine, Orange, CA, USA.
  • Department of Biomedical Engineering, University of California Irvine, Irvine, CA, USA.

ORCID-Profile: Jonathan Rt Lakey

Zitieren

APA

Kojayan, G. G., Flores, A., Li, S., Alexander, M., & Lakey, J. R. (2019). Cryopreserved Alginate-Encapsulated Islets Can Restore Euglycemia in a Diabetic Animal Model Better than Cryopreserved Non-encapsulated Islets. Cell Medicine. https://doi.org/10.1177/2155179019876641

Vancouver

Kojayan GG, Flores A, Li S, Alexander M, Lakey JR. Cryopreserved Alginate-Encapsulated Islets Can Restore Euglycemia in a Diabetic Animal Model Better than Cryopreserved Non-encapsulated Islets. Cell Medicine. 2019. doi:10.1177/2155179019876641

BibTeX
@article{Kojayan2019,
  author = {Kojayan, Greg G and Flores, Antonio and Li, Shiri and Alexander, Michael and Lakey, Jonathan Rt},
  title = {Cryopreserved Alginate-Encapsulated Islets Can Restore Euglycemia in a Diabetic Animal Model Better than Cryopreserved Non-encapsulated Islets},
  journal = {Cell Medicine},
  year = {2019},
  doi = {10.1177/2155179019876641}
}
Kostenlos starten →